Biotech Layoffs 2025 - Staff cuts could leave igm biosciences with fewer than 55 employees. The company is also halting development of two bispecific antibody t cell engagers for autoimmune diseases. Explore the causes behind recent biotech industry layoffs, including funding challenges, rising costs, and new regulations like the u. s. Yet biopharma layoff trends have remained high. Based on information in company press releases, warn notices, sec filings, reports from other media outlets and interviews, here are the biopharma companies that have. Overall, biopharma layoffs rose ever so slightly in 2025 compared to the year before, though the number of layoff rounds across big pharma skyrocketed by 281%. The tech layoff wave continued through 2025. Following significant workforce reductions in 2025 and 2023, 2025 saw more than 150,000 job cuts across 542 companies,. On the heels of a strong year of fda approvals, there are signs in early 2025 that the biotech sector is recovering. Examples include two recent biotech ipos, signs of investor.
Staff cuts could leave igm biosciences with fewer than 55 employees. The company is also halting development of two bispecific antibody t cell engagers for autoimmune diseases. Explore the causes behind recent biotech industry layoffs, including funding challenges, rising costs, and new regulations like the u. s. Yet biopharma layoff trends have remained high. Based on information in company press releases, warn notices, sec filings, reports from other media outlets and interviews, here are the biopharma companies that have.